SMTL ID : 4fyn.1

Crystal structure of spleen tyrosine kinase complexed with 3-(8-{4-[Ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,2-a]pyrazin-5-yl)-phenol

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.32 Å

Oligo State

monomer

Ligands

1 x 0VE: 3-[8-({4-[ethyl(2-hydroxyethyl)amino]phenyl}amino)imidazo[1,2-a]pyrazin-5-yl]phenol(Non-covalent)

0VE.1: 13 residues within 4Å: Chain A: L.25, V.33, A.48, K.50, M.96, E.97, M.98, A.99, E.100, G.102, L.149, S.159, D.160 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:V.33, A:K.50 Hydrogen bonds: A:A.99, A:A.99, A:D.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lucas, M.C. et al., Rational design of highly selective spleen tyrosine kinase inhibitors. J.Med.Chem. (2012)

Release Date

2013-01-30

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence